FDA product code KXK: Source, Brachytherapy, Radionuclide
KXK is the FDA product code for source, brachytherapy, radionuclide. It is a Class II device, regulated under 21 CFR 892.5730 and reviewed by the Radiology panel. FDA has cleared 151 510(k) submissions under KXK, 4 in the last five years, from 79 different applicants. The average 510(k) review took 131 days (median 90); 218 days on average over the last three years. FDA has posted 7 recalls for KXK devices.
Classification
| Field | Value |
|---|---|
| Device name | Source, Brachytherapy, Radionuclide |
| Device class | Class II |
| Regulation | 21 CFR 892.5730 |
| Review panel | RA — Radiology |
| Medical specialty | Radiology |
| Premarket route | 510(k) |
| Implant | Yes |
510(k) clearances per year for KXK
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 2 | 90 |
| 2018 | 1 | 129 |
| 2019 | 2 | 78 |
| 2020 | 3 | 199 |
| 2022 | 1 | 166 |
| 2023 | 1 | 55 |
| 2025 | 2 | 218 |
Compare with all 510(k) review times · Search every KXK clearance
Top KXK applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Cp Medical | 6 | 2007-07-18 |
| Implant Sciences Corp. | 6 | 2007-03-23 |
| Worldwide Medical Technologies, LLC | 6 | 2007-03-01 |
| Isoaid, LLC | 5 | 2025-07-15 |
| Isoray Medical, Inc. | 5 | 2020-12-31 |
74 more applicants have KXK clearances. See the full list in Caduvo.
Most recent KXK clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K252296 | Oncopatch, Inc. | OncoPatch | 2025-12-05 | 135 |
| K242818 | Isoaid, LLC | IsoSphere | 2025-07-15 | 300 |
| K223465 | Radiance Therapeutics, Inc. | RadianceTx Radionuclide Brachytherapy Source | 2023-01-11 | 55 |
| K221539 | Gt Medical Technologies | GammaTile | 2022-11-09 | 166 |
| K202267 | Isoray Medical, Inc. | Sirius MRI Markers, Cs-131 Preloaded Strands with Sirius MRI Markers in 18 Gauge Needles | 2020-12-31 | 142 |
Recalls for KXK devices
7 product recalls in 7 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2018-04-10.
| Year | Recalls |
|---|---|
| 2018 | 1 |
Frequently asked questions
What is FDA product code KXK?
KXK is the FDA product code for source, brachytherapy, radionuclide. It is a Class II device, regulated under 21 CFR 892.5730 and reviewed by the Radiology panel.
What device class is KXK?
Class II, regulation 21 CFR 892.5730. Typical premarket route: 510(k).
How long does a 510(k) take for product code KXK?
Across 151 cleared submissions the average was 131 days from receipt to decision (median 90).
Which companies have the most KXK clearances?
Cp Medical (6); Implant Sciences Corp. (6); Worldwide Medical Technologies, LLC (6); Isoaid, LLC (5); Isoray Medical, Inc. (5).
Have KXK devices been recalled?
Yes: 7 product recalls across 7 recall events; the most recent began 2018-04-10.
Next steps
- Run an FDA pathway report with predicate devices for product code KXK
- Run a recall and safety report across every KXK manufacturer
- Watch product code KXK for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Radiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times